Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for PIII.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 58.21M
March 31, 2026 27.80M
December 31, 2025 12.87M
September 30, 2025 14.67M
June 30, 2025 14.62M
March 31, 2025 30.66M
December 31, 2024 33.72M
September 30, 2024 -2.486M
June 30, 2024 56.14M
March 31, 2024 11.40M
December 31, 2023 -0.84M
September 30, 2023 -0.086M
Date Value
June 30, 2023 87.16M
March 31, 2023 14.10M
December 31, 2022 14.71M
September 30, 2022 -1.075M
June 30, 2022 -1.142M
March 31, 2022 -1.117M
December 31, 2021 210.98M
September 30, 2021 -0.0226M
June 30, 2021 12.54M
March 31, 2021 -0.0222M
December 31, 2020 34.47M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Elite Health Systems, Inc. 0.053M
The Joint Corp. (United States) -0.6953M
Concentra Group Holdings Parent, Inc. -24.67M
Astrana Health, Inc. -104.07M
Nutex Health, Inc. -35.19M